Literature DB >> 23433313

Incidence of hypotony and sympathetic ophthalmia following trans-scleral cyclophotocoagulation for glaucoma and a report of risk factors.

Jaskirat S Aujla1, Graham A Lee, Stephen J Vincent, Ravi Thomas.   

Abstract

OBJECTIVE: To report the incidence and risk factors for hypotony and estimate the risk of sympathetic ophthalmia following diode laser trans-scleral cyclophotocoagulation (TSCPC).
DESIGN: Retrospective study using data from a private tertiary glaucoma clinic and review of the literature. PARTICIPANTS: Seventy eyes of 70 patients with refractory glaucoma who received TSCPC treatment.
METHODS: Review of the records of consecutive patients who underwent TSCPC by a single ophthalmic surgeon and review of the literature. MAIN OUTCOME MEASURES: Hypotony (including phthisis bulbi), sympathetic ophthalmia.
RESULTS: Seven eyes (10%; CI 5-19%) developed hypotony and included 4 eyes that developed phthisis. Higher total energy delivered during TSCPC treatment was associated with an increased risk of hypotony: eyes that developed hypotony received a mean total energy of 192.5 ± 73.2 joules, compared to a mean of 152.9 ± 83.2 joules in hypotony-free cases. The risk of sympathetic ophthalmia estimated from a review of the published literature and current series was one in 1512, or 0.07% (CI 0.03%-0.17%).
CONCLUSIONS: Total laser energy is one of several risk factors that act in a sufficient component cause-model to produce hypotony in an individual patient. The small sample size precluded inference for other individual putative risk factors but titrating laser energy may help decrease the occurrence of hypotony. The risk of sympathetic ophthalmia calculated from the literature is likely an overestimate caused by publication bias.
© 2013 The Authors. Clinical and Experimental Ophthalmology © 2013 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  cyclophotocoagulation; diode laser; glaucoma; hypotony; sympathetic ophthalmia

Mesh:

Year:  2013        PMID: 23433313     DOI: 10.1111/ceo.12088

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  5 in total

1.  Ab interno tube ligation for refractory hypotony following non-valved glaucoma drainage device implantation.

Authors:  A Vergados; A A Mohite; Velota C T Sung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-22       Impact factor: 3.117

2.  Current and Future of Laser Therapy in the Management of Glaucoma.

Authors:  Feyzahan Ekici; Michael Waisbourd; L Jay Katz
Journal:  Open Ophthalmol J       Date:  2016-02-29

3.  Clinical classification, visual outcomes, and optical coherence tomographic features of 48 patients with posterior sympathetic ophthalmia.

Authors:  Hong Zhuang; Rui Zhang; Ting Zhang; Qing Chang; Gezhi Xu
Journal:  Orphanet J Rare Dis       Date:  2022-03-04       Impact factor: 4.123

4.  Transscleral cyclophotocoagulation and its histological effects on the conjunctiva.

Authors:  Nicholas Y Q Tan; Marcus Ang; Anita S Y Chan; Veluchamy A Barathi; Clement C Tham; Keith Barton; Chelvin C A Sng
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

5.  First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma.

Authors:  Enrico Bernardi; Marc Töteberg-Harms
Journal:  Int Ophthalmol       Date:  2022-02-03       Impact factor: 2.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.